Single-cell genotyping demonstrates complex clonal diversity in acute myeloid leukemia
- 1 April 2015
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 7 (281) , 281re2
Abstract
Clonal evolution in cancer—the selection for and emergence of increasingly malignant clones during progression and therapy, resulting in cancer metastasis and relapse—has been highlighted as an important phenomenon in the biology of leukemia and other cancers. Tracking mutant alleles to determine clonality from diagnosis to relapse or from primary site to metastases in a sensitive and quantitative manner is most often performed using next-generation sequencing. Such methods determine clonal frequencies by extrapolation of allele frequencies in sequencing data of DNA from the metagenome of bulk tumor samples using a set of assumptions. The computational framework that is usually used assumes specific patterns in the order of acquisition of unique mutational events and heterozygosity of mutations in single cells. However, these assumptions are not accurate for all mutant loci in acute myeloid leukemia (AML) samples. To assess whether current models of clonal diversity within individual AML samples are appropriate for common mutations, we developed protocols to directly genotype AML single cells. Single-cell analysis demonstrates that mutations of FLT3 and NPM1 occur in both homozygous and heterozygous states, distributed among at least nine distinct clonal populations in all samples analyzed. There appears to be convergent evolution and differential evolutionary trajectories for cells containing mutations at different loci. This work suggests an underlying tumor heterogeneity beyond what is currently understood in AML, which may be important in the development of therapeutic approaches to eliminate leukemic cell burden and control clonal evolution-induced relapse.Keywords
Funding Information
- NIH (P01 CA91955, R01 CA149566, R01 CA114563, R01 CA140657)
- American Cancer Society (#117209-RSG-09-163-01-CNE, #117749-PF-09-288-01-CCE)
This publication has 24 references indexed in Scilit:
- Clonal Architecture of Secondary Acute Myeloid Leukemia Defined by Single-Cell SequencingPLOS Genetics, 2014
- Functional Heterogeneity of Genetically Defined Subclones in Acute Myeloid LeukemiaCancer Cell, 2014
- Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid LeukemiaScience Translational Medicine, 2012
- Clonal competition with alternating dominance in multiple myelomaBlood, 2012
- The Origin and Evolution of Mutations in Acute Myeloid LeukemiaCell, 2012
- Genetic heterogeneity and cancer drug resistanceThe Lancet Oncology, 2012
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid LeukemiaNew England Journal of Medicine, 2012
- Clonal evolution of acute leukemia genomesOncogene, 2012
- Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)Blood, 2006
- Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosisBlood, 2002